Recent strategies to improve boron dipyrromethene (BODIPY) for photodynamic cancer therapy: an updated review

Volume: 17, Issue: 11, Pages: 1691 - 1708
Published: Nov 1, 2018
Abstract
BODIPYs are photosensitizers activatable by light to generate highly reactive singlet oxygen (1O2) from molecular oxygen, leading to tissue damage in the photoirradiated region. Despite their extraordinary photophysical characteristics, they are not featured in clinical photodynamic therapy. This review discusses the recent advances in the design and/or modifications of BODIPYs since 2013, to improve their potential in photodynamic cancer...
Paper Details
Title
Recent strategies to improve boron dipyrromethene (BODIPY) for photodynamic cancer therapy: an updated review
Published Date
Nov 1, 2018
Volume
17
Issue
11
Pages
1691 - 1708
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.